Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Morandi

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cells|March 14, 2020
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib<sup>.</sup>Nicla Lorito, Marina Bacci, Alfredo Smiriglia, et al.
Hepatology (Baltimore, Md.)|August 21, 2023
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytesMarta A Kowalik, Keiko Taguchi, Marina Serra, et al.
Oncogene|April 3, 2019
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transferLuigi Ippolito, Andrea Morandi, Maria Letizia Taddei, et al.
Journal of Hepatology|December 15, 2015
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survivalSandra Mattu, Francesca Fornari, Luca Quagliata, et al.
Nano Letters|April 14, 2023
Background-Free Near-Infrared Biphoton Emission from Single GaAs NanowiresGrégoire Saerens, Thomas Dursap, Ian Hesner, et al.
EMBO Reports|June 21, 2024
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancerLuigi Ippolito, Assia Duatti, Marta Iozzo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2026
Cell Cycle Control of Nuclear Metabolism Couples Phosphatidylinositol Signaling to Histone MethylationAntoni Gañez-Zapater, Savvas Kourtis, Camilla Reiter Elbæk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2022
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancerLuca Visani, Lorenzo Livi, Ivica Ratosa, et al.
EMBO Molecular Medicine|June 26, 2024
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancerNicla Lorito, Angela Subbiani, Alfredo Smiriglia, et al.
Hepatology Communications|January 29, 2026
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic diseaseGiovanni Inzalaco, Sara Gargiulo, Denise Bonente, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cells|March 14, 2020
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib<sup>.</sup>Nicla Lorito, Marina Bacci, Alfredo Smiriglia, et al.
Hepatology (Baltimore, Md.)|August 21, 2023
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytesMarta A Kowalik, Keiko Taguchi, Marina Serra, et al.
Oncogene|April 3, 2019
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transferLuigi Ippolito, Andrea Morandi, Maria Letizia Taddei, et al.
Journal of Hepatology|December 15, 2015
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survivalSandra Mattu, Francesca Fornari, Luca Quagliata, et al.
Nano Letters|April 14, 2023
Background-Free Near-Infrared Biphoton Emission from Single GaAs NanowiresGrégoire Saerens, Thomas Dursap, Ian Hesner, et al.
EMBO Reports|June 21, 2024
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancerLuigi Ippolito, Assia Duatti, Marta Iozzo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2026
Cell Cycle Control of Nuclear Metabolism Couples Phosphatidylinositol Signaling to Histone MethylationAntoni Gañez-Zapater, Savvas Kourtis, Camilla Reiter Elbæk, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2022
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancerLuca Visani, Lorenzo Livi, Ivica Ratosa, et al.
EMBO Molecular Medicine|June 26, 2024
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancerNicla Lorito, Angela Subbiani, Alfredo Smiriglia, et al.
Hepatology Communications|January 29, 2026
MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic diseaseGiovanni Inzalaco, Sara Gargiulo, Denise Bonente, et al.
Pageof 7